O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.82B
AUM Growth
-$649M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
132
New
Increased
Reduced
Closed

Top Buys

1
+$127M
2
+$80.2M
3
+$78.7M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$43.5M
5
CYTK icon
Cytokinetics
CYTK
+$42.4M

Top Sells

1
+$81.3M
2
+$55.2M
3
+$51.3M
4
MRK icon
Merck
MRK
+$50.1M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$47.5M

Sector Composition

1 Healthcare 98.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$401M 8.33%
15,021,721
2
$334M 6.94%
2,718,735
3
$282M 5.86%
3,160,300
-112,700
4
$261M 5.41%
337,600
5
$210M 4.35%
401,700
-32,100
6
$179M 3.72%
7,959,538
7
$128M 2.66%
938,120
+635,900
8
$124M 2.57%
344,400
9
$117M 2.43%
963,400
+8,900
10
$117M 2.42%
189,700
-14,800
11
$113M 2.35%
1,785,571
12
$100M 2.08%
792,000
+10,000
13
$98.5M 2.05%
2,817,347
+492,900
14
$97.8M 2.03%
415,600
+165,300
15
$93.6M 1.94%
+5,693,589
16
$87.4M 1.82%
8,288,510
17
$84.8M 1.76%
+1,145,302
18
$82.6M 1.71%
829,900
-486,100
19
$80.6M 1.67%
3,027,328
20
$77.9M 1.62%
509,100
-303,900
21
$76.2M 1.58%
575,000
22
$74.5M 1.55%
1,584,005
+817,099
23
$70.3M 1.46%
3,812,215
24
$66.2M 1.37%
130,900
-48,100
25
$65.4M 1.36%
413,000
-274,500
1
2 3 4 5